IRWIN NATURALS SUB VTS - IWINF STOCK NEWS

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) has announced a definitive agreement to acquire Keta Media, LLC, the leading platform for ketamine-assisted therapy clinics. This acquisition aims to enhance profitability and expand Irwin's Emergence Clinics chain across the U.S. and beyond. Irwin expects to leverage Keta Media's networks in over 45 states to improve patient outcomes and accelerate clinic transactions. The deal involves a combination of cash and stock, with additional payments tied to profitability milestones. Regulatory approvals are pending.

Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) has announced its agreement to acquire Happier You, LLC, a ketamine clinic in central Ohio, expanding its national chain of psychedelic mental-health clinics. This acquisition will integrate Happier You into the Irwin Naturals Emergence brand, which already operates clinics across five states. The move aims to enhance access to mental health treatments through economies of scale, providing sliding-scale discounts. The transaction is subject to customary closing conditions and regulatory approvals.

Irwin Naturals Inc. has announced a significant licensing agreement with 42 Degrees Processing LLC to produce and distribute its THC products in Michigan, a rapidly growing cannabis market. This partnership aims to leverage 42 Degrees' advanced processing capabilities to augment Irwin’s popular health products with THC, targeting Michigan’s 1,000 dispensaries. The agreement marks progress in Irwin's strategy to establish a presence in all 38 states where cannabis is legal, furthering its mission to expand into the THC and psychedelic markets.

Irwin Naturals Inc. (CSE: IWIN) reported Q2 2022 results, with revenues decreasing by 18% to $21.8 million due to supply chain issues and product transitions. Despite this revenue drop, the company maintained profitability with a net profit of $111,000. CFO Philippe Faraut outlined the ongoing cannabis licensing and ketamine clinic expansion strategy aimed at increasing revenue streams. The company has acquired 11 clinics and launched brand licensing in four U.S. states and Canada, positioning itself for future growth.

Irwin Naturals Inc. has acquired a ketamine treatment clinic in Vermont, marking its expansion into psychedelic mental healthcare. This acquisition follows the company’s previous purchase of five Florida clinics and others across the U.S. CEO Klee Irwin emphasized the aim to become a leading national brand in this emerging field. The clinic will enhance patient access through economies of scale and offer sliding-scale discounts. With over 100,000 retail locations, Irwin Naturals has established brand loyalty, positioning itself as a trusted entity in holistic healthcare.

Irwin Naturals Inc. (CSE: IWIN, OTC: IWINF) has announced a licensing agreement with Entourage Brands to distribute cannabis-infused products in Canada. The deal will enhance Irwin's product line with five varieties of cannabis softgels, including formulations with CBD and THC. Irwin Naturals aims to leverage its strong brand presence, recognized in 80% of American households, to expand internationally. The cannabis market in Canada is estimated at C$2.7 billion annually, and this partnership is seen as a significant step in tapping into that potential.

Irwin Naturals Inc. has acquired the assets of New England Ketamine in Salem, New Hampshire, marking its third acquisition in five months. This expansion aims to create a national network of psychedelic mental health clinics using ketamine treatments. Irwin has also reached agreements for additional facilities in Georgia and Vermont, with plans to lower operating costs and offer sliding-scale discounts. The company will issue 24,000 subordinate voting shares as part of capital advisory fees. Their brand is recognized by over 100 million people across North America.

Irwin Naturals has announced the acquisition of two clinics in Georgia, expanding its chain of psychedelic mental health centers. This acquisition, part of a broader strategy to establish a national presence, underscores the company's commitment to integrating treatments like ketamine therapy. With this addition, Irwin has acquired nine clinics across four states within three months. The deal is structured to align seller interests with performance goals, enhancing potential profitability. Irwin's brand recognition, available in over 100,000 stores, is expected to facilitate accessibility to these treatments.

Irwin Naturals (CSE: IWIN) announced the acquisition of Preventive Medicine, expanding its Emergence clinics focusing on wellness and ketamine therapy. This marks the company's eighth ketamine clinic, bringing its portfolio to four states. CEO Klee Irwin emphasized the strategic goal of acquiring profitable operations to enhance revenue. The total deal, subject to regulatory approvals, involves a combination of cash and stock tied to performance milestones. This partnership aims to broaden the reach of holistic care and increase operational capabilities in Vermont.